Omega Fund Management, LLC

Q3 2025 13F Holdings

  • Location
    boston, MA
  • Num holdings

    12

  • Value ($000)

    $222,365

  • Date Filed
    11/14/2025
  • Form type
    13F-HR
  • CIK
    0001637359
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
---

Kestra Med Technologies Ltd

COMMON STOCK
G52441105
$39.11M
18 %

1,645,893

---

Beta Bionics Inc.

COMMON STOCK
08659B102
$38.15M
17 %

1,920,125

---

BridgeBio Oncology Therapeutics Inc.

COMMON STOCK
107924102
$38.09M
17 %

3,289,661

---

Bicara Therapeutics Inc.

COMMON STOCK
055477103
$34.81M
16 %

2,204,650

N
NUVB

Nuvation Bio

COMMON STOCK CLASS A
67080N101
$32.68M
15 %

8,831,089

---

Upstream Bio Inc.

COMMON STOCK
91678A107
$25.51M
12 %

1,356,293

---

ImageneBio, Inc.

COMMON STOCK
45175G207
$3.71M
2 %

455,361

E
ENGN

enGene Holdings Inc.

COMMON STOCK
29286M105
$3.60M
2 %

526,357

S
SANA

Sana Biotechnology, Inc.

COMMON STOCK
799566104
$3.00M
1 %

843,750

A
ALMS

Alumis Inc.

COMMON STOCK
022307102
$2.61M
1 %

653,223

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 12